Pinning Down Orion Oyj's (HEL:ORNBV) P/E Is Difficult Right Now
Jan 20
Have your own idea? Try our Stock Screener
Finnish (OMX) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies15
- 7D7.6%
- 3M2.1%
- 1Y16.2%
- YTD8.3%
In the last week, the Healthcare industry is up 7.6%, with Orion Oyj up 9.6%. Meanwhile, Biohit Oyj actually underperformed within the industry, shrinking 16% in the last week. This means that the industry has gained 16% over the past year. Earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Finnish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | €10.1b | €5.2b | €274.3m | 25.6x | 36.9x | 1.9x |
| Thu, 19 Dec 2024 | €9.1b | €5.2b | €274.3m | 19.5x | 33.3x | 1.7x |
| Sat, 16 Nov 2024 | €9.3b | €5.2b | €275.8m | 20.8x | 33.8x | 1.8x |
| Mon, 14 Oct 2024 | €10.0b | €5.0b | €144.2m | 25.3x | 69.2x | 2x |
| Wed, 11 Sep 2024 | €10.1b | €5.0b | €143.6m | 25.1x | 70.4x | 2x |
| Fri, 09 Aug 2024 | €9.3b | €5.0b | €123.1m | 30.2x | 75.7x | 1.9x |
| Sun, 07 Jul 2024 | €8.8b | €4.9b | €115.7m | 27.8x | 75.8x | 1.8x |
| Tue, 04 Jun 2024 | €8.4b | €4.9b | €118.1m | 28.4x | 71.1x | 1.7x |
| Thu, 02 May 2024 | €7.8b | €4.9b | €116.4m | 32.6x | 67.4x | 1.6x |
| Sat, 30 Mar 2024 | €7.5b | €4.8b | €108.0m | 30x | 69.2x | 1.5x |
| Mon, 26 Feb 2024 | €8.0b | €4.8b | €110.2m | 26.9x | 72.8x | 1.7x |
| Wed, 24 Jan 2024 | €8.6b | €4.8b | €135.4m | 33.1x | 63.4x | 1.8x |
| Fri, 22 Dec 2023 | €8.0b | €4.8b | €135.4m | 31.6x | 59.3x | 1.7x |
| Sun, 19 Nov 2023 | €7.7b | €4.8b | €134.3m | 30.5x | 57.3x | 1.6x |
| Tue, 17 Oct 2023 | €7.8b | €5.0b | €270.4m | 26.8x | 28.8x | 1.6x |
| Thu, 14 Sep 2023 | €7.7b | €5.0b | €269.6m | 27.5x | 28.4x | 1.5x |
| Sat, 12 Aug 2023 | €7.5b | €5.0b | €276.1m | 23.8x | 27.2x | 1.5x |
| Mon, 10 Jul 2023 | €8.0b | €5.0b | €315.2m | 38.5x | 25.3x | 1.6x |
| Wed, 07 Jun 2023 | €8.6b | €5.0b | €315.2m | 40x | 27.2x | 1.7x |
| Fri, 05 May 2023 | €9.0b | €5.0b | €314.2m | 44.2x | 28.8x | 1.8x |
| Sun, 02 Apr 2023 | €8.7b | €5.0b | €343.2m | 36.4x | 25.5x | 1.8x |
| Tue, 28 Feb 2023 | €9.5b | €5.0b | €335.7m | 37.8x | 28.2x | 1.9x |
| Thu, 26 Jan 2023 | €10.0b | €5.3b | €373.8m | 19.4x | 26.6x | 1.9x |
| Sat, 24 Dec 2022 | €10.4b | €5.3b | €373.8m | 18.4x | 27.8x | 1.9x |
| Mon, 21 Nov 2022 | €9.7b | €5.3b | €384.8m | 18.9x | 25.2x | 1.8x |
| Wed, 19 Oct 2022 | €9.2b | €5.0b | €272.5m | 17.6x | 33.9x | 1.8x |
| Fri, 16 Sep 2022 | €9.9b | €5.0b | €284.2m | 18.9x | 34.8x | 2x |
| Sun, 14 Aug 2022 | €10.5b | €5.0b | €285.4m | 19.8x | 36.8x | 2.1x |
| Tue, 12 Jul 2022 | €10.2b | €4.9b | €277.1m | 27x | 36.8x | 2.1x |
| Thu, 09 Jun 2022 | €9.4b | €4.9b | €277.1m | 27.4x | 33.8x | 1.9x |
| Sat, 07 May 2022 | €9.0b | €4.9b | €278.1m | 26.2x | 32.5x | 1.8x |
| Mon, 04 Apr 2022 | €10.3b | €4.8b | €280.7m | 30.2x | 36.6x | 2.2x |
| Wed, 02 Mar 2022 | €9.9b | €4.8b | €277.8m | 29.7x | 35.8x | 2.1x |
| Fri, 28 Jan 2022 | €9.7b | €4.6b | €269.9m | 27.2x | 35.9x | 2.1x |
Price to Earnings Ratio
35.9x
Current Industry PE
- Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 36.9x which is lower than its 3-year average PE of 42.9x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 4.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare sector?
| FI Market | 2.03% | |
| Healthcare | 7.57% | |
| Pharma | 9.50% | |
| Medical Equipment | 8.12% | |
| Life Sciences | 3.87% | |
| Healthcare Services | 1.75% | |
| Healthtech | -2.23% | |
| Biotech | -10.58% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 237x.
- Analysts expect its future annual earnings growth (26.9%) to be largely in line with prior year's earnings growth.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 41% over the next 5 years.
- This is better than its past earnings growth rate of 26% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 9.2% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ORNBV Orion Oyj | €49.59 | 12.2% +€757.3m | 15.3% | PE21x | |
| REG1V Revenio Group Oyj | €29.96 | 16.8% +€114.9m | 16.6% | PE41.7x | |
| NXTMH Nexstim | €8.80 | 3.5% +€2.1m | 246.5% | PS6.7x | |
| OKDBV Oriola Oyj | €0.93 | 0.8% +€1.3m | -13.5% | PS0.1x | |
| HEALTH Nightingale Health Oyj | €2.72 | 0.4% +€603.4k | 136.5% | PS37.7x |
